Calprotectin in Patients with Rheumatic Immunomediated Adverse Effects Induced by Checkpoints Inhibitors

Calprotectin in Patients with Rheumatic Immunomediated Adverse Effects Induced by Checkpoints Inhibitors

Background: this is an exploratory study to evaluate calprotectin serum levels in patients with rheumatic immune-related adverse events (irAEs) induced by immune checkpoint inhibitor (ICI) treatment. Methods: this is a retrospective observational study including patients with irAEs rheumatic syndrom...

Full description

Bibliographic Details
Main Authors: Beatriz Frade-Sosa, Chafik Alejandro Chacur, Josep M. Augé, Andrés Ponce, Juan C. Sarmiento-Monroy, Ana Belén Azuaga, Nuria Sapena, Julio Ramírez, Virginia Ruiz-Esquide, Rosa Morlà, Sandra Farietta, Patricia Corzo, Juan D. Cañete, Raimon Sanmartí, José A. Gómez-Puerta
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Cancers
Subjects:
calprotectin
immune checkpoint inhibitors
immune-related adverse events
rheumatoid arthritis
Online Access:https://www.mdpi.com/2072-6694/15/11/2984

Similar Items

Similar Items